Women's Desired Information about Human Papillomavirus

Cancer

Volumn 100, Issue 2, 2004, Pages 315-320

  Anhang, Rebecca ^a   Wright Jr , Thomas C ^b   Smock, Laura ^c   Goldie, Sue J ^a  

^a HARVARD CENTER FOR RISK ANALYSIS   (United States)

^b Columbia University ^*  (United States)

^c MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

Cervical cancer screening; DNA testing; Focus group; Human papillomavirus; Sexually transmitted disease

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; CLINICAL ARTICLE; EDUCATION; ETHNIC GROUP; FAMILY PLANNING; FEMALE; HUMAN; LOWEST INCOME GROUP; PAPANICOLAOU TEST; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SEXUAL TRANSMISSION; SOCIAL PSYCHOLOGY; SUBSTANCE ABUSE; UTERINE CERVIX CARCINOMA; WART VIRUS;

ADOLESCENT; ADULT; ATTITUDE TO HEALTH; FEMALE; HEALTH EDUCATION; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; SEXUALLY TRANSMITTED DISEASES, VIRAL; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

EID: 0346724525     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20007     Document Type: Article

References (31)

1. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244-265.
2. Schiffman M, Herrero R, Hildesheim A, et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA. 2000;283:87-93.
3. Wright TC Jr., Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA. 2000;283:81-86.
4. Mandelblatt JS, Lawrence WF, Womack SM, et al. Benefits and costs of using HPV testing to screen for cervical cancer. JAMA. 2002;287:2372-2381.
5. Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA. 2002;287:2382-2390.
6. Wright TC Jr., Schiffman M. Adding a test for human papillomavirus DNA to cervical-cancer screening. N Engl J Med. 2003;348:489-490.
7. Food and Drug Administration. FDA approves expanded use of HPV test [monograph online]. Available from URL: http://www.fda.gov/bbs/topics/NEWS/2003/NEW00890.html [accessed 14 November 2003].
8. Wright TC Jr., Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002;287:2120-2129.
9. Campion MJ, Brown JR, McCance DJ, et al. Psychosexual trauma of an abnormal cervical smear. Br J Obstet Gynaecol. 1988;95:175-181.
10. Follen M, Richards-Kortum R. Emerging technologies and cervical cancer. J Natl Cancer Inst. 2000;92:363-365.
11. Littenberg B. Technology assessment in medicine. Acad Med. 1992;67:424-428.
12. Harper DM, Noll WW, Belloni DR, Cole BF. Randomized clinical trial of PCR-determined human papillomavirus detection methods: self-sampling versus clinician-directed-biologic concordance and women's preferences. Am J Obstet Gynecol. 2002;186:365-373.
13. Kaiser Family Foundation. National survey of public knowledge of HPV, the human papillomavirus [monograph online]. Available from URL: www.kff.org/content/2000/ 20000217a/HPVChartpack2.pdf [accessed 14 November 2003].
14. Baer H, Allen S, Braun L. Knowledge of human papillomavirus infection among young adult men and women: implications for health education and research. J Community Health. 2000;25:67-78.
15. Dell DL, Chen H, Ahmad F, Stewart DE. Knowledge about human papillomavirus among adolescents. Obstet Gynecol. 2000;96:653-656.
16. Ramirez JE, Ramos DM, Clayton L, Kanowitz S, Moscicki AB. Genital human papillomavirus infections: knowledge, perception of risk, and actual risk in a nonclinic population of young women. J Womens Health. 1997;6:113-121.
17. Yacobi E, Tennant C, Ferrante J, Pal N, Roetzheim R. University students' knowledge and awareness of HPV. Prev Med. 1999;28:535-541.
18. Mays RM, Zimet GD, Winston Y, Kee R, Dickes J, Su L. Human papillomavirus, genital warts, Pap smears, and cervical cancer: knowledge and beliefs of adolescent and adult women. Health Care Women Int. 2000;21:361-374.
19. Vail-Smith K, White DM. Risk level, knowledge, and preventive behavior for human papillomaviruses among sexually active college women. J Am Coll Health. 1992;40:227-230.
20. Hudelson P. Qualitative research for health programmes. Geneva: World Health Organization, 1996.
21. Rice P, Ezzy D. Qualitative research methods: a health focus. Boston: Oxford University Press, 1999.
22. National Institute of Allergy and Infectious Diseases. Strategic plan for addressing health disparities [monograph online]. Available from URL: http://www.niaid.nih.gov/director/congress/2001/healthdisl.htm [accessed 14 November 2003].
23. U.S. Department of Health and Human Services. Healthy People 2010: understanding and improving health, 2nd edition. Washington, DC: U.S. Government Printing Office, 2000.
24. Palefsky J, Handley J. What your doctor may not tell you about HPV and abnormal Pap smears. New York: Warner Books, 2002.
25. Henderson G, Yasgur B. Women at risk: the HPV epidemic and your cervical health. New York: Avery, 2002.
26. American Social Health Association. A patient guide: HPV in perspective. Research Triangle Park, NC: ASHA Publications, 1998.
27. American Social Health Association. HPV and cervical cancer screening. Research Triangle Park, NC: ASHA Publications, 2002.
28. Mays N, Pope C. Rigour and qualitative research. BMJ. 1995;311:109-112.
29. Gilbert LK, Alexander L, Grosshans JF, Jolley L. Answering frequently asked questions about HPV. Sex Transm Dis. 2003;30:193-194.
30. Mindel A. Psychological and psychosexual implications of herpes simplex virus infections. Scand J Infect Dis Suppl. 1996;100:27-32.
31. Guba EG, Lincoln YS. Competing paradigms in qualitative research. In: Denzin NK, Lincoln YS, editors. Handbook of qualitative research. London: Sage, 1994:105-117.